A US appeals court on Wednesday temporarily suspended an order blocking the French pharmaceutical group Sanofi and its American partner Regeneron from selling their anti-cholesterol drug Praluent.
Medications
Feb 9, 2017
0
5
In what may be a major leap forward in the quest for new treatments of the most common form of cardiovascular disease, scientists at Johns Hopkins report they have found a way to halt and reverse the progression of atherosclerosis ...
Bio & Medicine
Jun 23, 2015
0
388
(PhysOrg.com) -- Scientists from Imperial College London and Diamond Light Source have revealed the structure of a cholesterol-lowering-drug target. Published in the journal Nature, this finding could lead to much more effective ...
Biochemistry
Oct 6, 2011
0
0
A protein has been discovered that may have a profound effect on cholesterol metabolism. That discovery raises the possibility that the protein, dubbed IDOL, could be a powerful target for cholesterol-lowering drugs, says ...
Cell & Microbiology
May 17, 2011
0
0
A needle-in-the-haystack search through nearly 390,000 chemical compounds had led scientists to a substance that can sneak through the protective barrier surrounding the brain with effects promising for new drugs for Parkinson's ...
Biochemistry
Apr 20, 2011
0
0
The biggest U.S.-based drugmaker will change leaders in January when Pfizer Chief Operating Officer Albert Bourla replaces CEO Ian Read, who has led the company for nearly eight years.
Business
Oct 1, 2018
0
4
Contrary to common perception, state and local police are often on the front lines against product counterfeiting, yet it's unclear how prepared they are to deal with the growing crime, according to a new report from two ...
Social Sciences
Feb 22, 2012
0
0
